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Abstract
Bordetella adenylate cyclase toxin-hemolysin (CyaA) penetrates the cytoplasmic membrane of phagocytes and employs two
distinct conformers to exert its multiple activities. One conformer forms cation-selective pores that permeabilize phagocyte
membrane for efflux of cytosolic potassium. The other conformer conducts extracellular calcium ions across cytoplasmic
membrane of cells, relocates into lipid rafts, translocates the adenylate cyclase enzyme (AC) domain into cells and converts
cytosolic ATP to cAMP. We show that the calcium-conducting activity of CyaA controls the path and kinetics of endocytic
removal of toxin pores from phagocyte membrane. The enzymatically inactive but calcium-conducting CyaA-AC
2 toxoid
was endocytosed via a clathrin-dependent pathway. In contrast, a doubly mutated (E570K+E581P) toxoid, unable to
conduct Ca
2+ into cells, was rapidly internalized by membrane macropinocytosis, unless rescued by Ca
2+ influx promoted in
trans by ionomycin or intact toxoid. Moreover, a fully pore-forming CyaA-DAC hemolysin failed to permeabilize phagocytes,
unless endocytic removal of its pores from cell membrane was decelerated through Ca
2+ influx promoted by molecules
locked in a Ca
2+-conducting conformation by the 3D1 antibody. Inhibition of endocytosis also enabled the native B.
pertussis-produced CyaA to induce lysis of J774A.1 macrophages at concentrations starting from 100 ng/ml. Hence, by
mediating calcium influx into cells, the translocating conformer of CyaA controls the removal of bystander toxin pores from
phagocyte membrane. This triggers a positive feedback loop of exacerbated cell permeabilization, where the efflux of
cellular potassium yields further decreased toxin pore removal from cell membrane and this further enhances cell
permeabilization and potassium efflux.
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Introduction
By instantaneously disrupting bactericidal functions of host
phagocytes, the adenylate cyclase toxin-hemolysin (CyaA, ACT,
or AC-Hly) plays a major role in virulence of pathogenic Bordetellae
[1]. The toxin rapidly paralyzes phagocytes [1,2] by translocating
across their cytoplasmic membrane an N-terminal adenylate
cyclase enzyme (AC) domain (,400 residues) that binds cytosolic
calmodulin and converts ATP to a key signaling molecule, cAMP
[1]. In parallel, the multidomain ,1300 residues-long RTX
(Repeat in ToXin) cytolysin moiety of CyaA acts independently as
a pore-forming leukotoxin and hemolysin [1]. This employs a
hydrophobic pore-forming domain (residues 500 to 700), a domain
with covalently palmitoylated lysine residues 860 and 983, and a
typical calcium-binding RTX repeat domain within the last 700
residues of CyaA that accounts for receptor binding [1]. CyaA can
oligomerize into small cation-selective pores that mediate efflux of
cytosolic potassium ions from cells [3–6], eventually provoking
colloid-osmotic cell lysis [7–9]. This activity synergizes with
cytotoxic signaling of the translocated AC enzyme in bringing
about the final cytotoxic action of CyaA [8,9].
The structure of CyaA in target membrane remains unknown.
Accumulated indirect evidence strongly suggests that the cell-
invasive AC and the pore-forming activities are associated with
distinct subpopulations of CyaA conformers within target cell
membrane. Indeed, translocation of the AC domain across cellular
membrane and the pore-forming activity of CyaA can be
dissociated by temperature, calcium concentrations, or altered
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activities can be largely shifted in either direction by specific
residue substitutions. Several CyaA variants with strongly
enhanced pore-forming activity and reduced or nil capacity to
deliver the AC domain into cells could be generated. Recently, a
CyaA defective in formation of toxin pores but intact in AC
delivery into cells could also be constructed [3,6,12]. Summarizing
this evidence, a model was proposed that predicts the co-existence
of two distinct toxin conformers inside target cell membrane.
These would operate in parallel and would employ the same
segments of the hydrophobic domain in an alternative manner.
One conformer would insert into cell membrane as toxin
translocation precursor that accomplishes delivery of the AC
domain into cells (cell-invasive activity). The second conformer
would account for formation of oligomeric CyaA pores [3,6,12].
The primary targets of CyaA appear to be host myeloid
phagocytes, to which the toxin binds through their aMb2 integrin,
known as CD11b/CD18, CR3 or Mac-1 [13]. Recently, we could
show that AC translocation into cells occurs in two steps. First, the
membrane–inserted translocation precursors of CyaA generate a
calcium-conducting path across cell membrane and mediate influx
of extracellular calcium ions into cells [14]. The incoming Ca
2+
than activates calpain-mediated processing of the talin tether of
CD11b/CD18, which triggers relocation of the toxin-receptor
complex into cholesterol-rich membrane lipid rafts. There the
translocation of the AC domain into cytosol of cells across the
cytoplasmic membrane of phagocytes is completed [15]. Unlike
for most other enzymatic toxins, the capacity of CyaA to deliver its
AC enzyme component into target cells does not depend on
receptor-mediated endocytosis. Instead, the AC domain translo-
cates into cytosol directly across the cytoplasmic membrane of
phagocytes. Indeed, inhibitors of endocytic pathways interfere
neither with translocation of the AC domain into cells and
elevation of cytosolic cAMP, nor with AC domain-mediated
delivery of inserted CD8
+ T cell epitopes into the cytosol of
antigen presenting cells [16–18]. Clathrin-dependent endocytic
uptake of CyaA together with its receptor CD11b/CD18 has,
however, previously been observed [19,20] and it was found to
account for the capacity of CyaA-AC
2 toxoids to deliver cargo
antigens into dendritic cells for endosomal processing and MHC
II-restricted presentation to CD4
+ T cells [18].
Therefore, we analyzed here the mechanism of endocytic
uptake of CyaA from cell membrane and its relevance for toxin
action. We show that by conducting calcium ions across the target
membrane into cytosol of cells, the translocating CyaA molecules
control the rate of toxin pore removal from cellular membrane
and thereby support the permeabilization of phagocytes.
Results
Functional integrity of hydrophobic domain determines
the path of endocytic trafficking of CyaA-AC
2 toxoid
Recently we found that despite binding to CD11b/CD18, the
CyaA constructs lacking the hydrophobic domain failed to deliver
a fused MalE antigen for presentation to CD4
+ T lymphocytes by
dendritic cells (Figure S1). To address the role of functional
integrity of CyaA in its endocytic trafficking, we employed live
microscopy imaging.
To avoid the interference of massive phagocyte ruffling and
death from ATP depletion and cAMP signaling provoked by
enzymatically active CyaA at concentrations required for imaging
[8,21], we used fluorescently labeled and enzymatically inactive
CyaA-AC
2 toxoids. To enable assessment of their capacity to
deliver antigens for presentation on MHC class I and II molecules,
the toxoids were further tagged by insertion of a CD8
+ T-cell
epitope (SIINFEKL) from ovalbumin at position 336 and of a
MalE CD4
+ T-cell epitope (NGKLIAYPIAVEALS) at position
108 of the AC domain, respectively. Trafficking of such tagged
dCyaA was then compared to that of a doubly mutated CyaA-
E570K+E581P-AC
2 toxoid (dCyaA-KP) that carried a combina-
tion of debilitating substitutions of glutamate residues at positions
570 and 581 within the pore-forming domain. That construct was
previously shown to retain a full capacity to bind the toxin
receptor CD11b/CD18, without being able to conduct calcium
ions into cells, to associate with lipid rafts and translocate the AC
domain across cell membrane, or to form oligomeric CyaA pores
within cellular membrane, respectively [3,15].
As shown in Figure 1, insertion of the epitope tags and
fluorescent labeling did not alter the expected properties of the
dCyaA toxoid, which elevated [Ca
2+]i in J774A.1 cells (Figure 1A)
and relocated into lipid rafts in J774A.1 membrane (Figure 1B). As
also expected, the dCyaA-KP toxoid lacked all these activities.
When examined by live cell imaging, the two fluorescently labeled
toxoids exhibited intriguingly different kinetics and patterns of
endocytic uptake. As documented by representative images in
Figure 1C and quantified in Figure 1D, dCyaA was detected
predominantly within the plasma membrane, or in fluorescent
vesicles located beneath the membrane of J774A.1 cells through-
out the 20 minutes of incubation at 37uC (Video S1). In contrast,
dCyaA-KP was taken-up much faster and accumulated massively
within endocytic vesicles dispersed through the cytosol of cells
already within 5 minutes from toxoid addition. The dCyaA-KP
toxoid was then almost completely removed from cell membrane
within 10 minutes (Figure 1C, Video S2), as quantified by
counting of the intracellularly located fluorescent vesicles for a
set of inspected cells (Figure 1D, see Figure S2 for the method).
Identical results were observed upon swapping of the fluorescent
labels (not shown), thus excluding the impact of the used dyes on
toxoid trafficking. While the two toxoids entered into quite
different endocytic pathways, the uptake of both was receptor-
mediated and depended on toxoid binding to CD11b/CD18.
Blocking of the receptor by the M1/70 antibody abrogated,
Author Summary
The adenylate cyclase toxin (CyaA) of pathogenic Borde-
tellae eliminates the first line of host innate immune
defense by inhibiting the oxidative burst and complement-
mediated opsonophagocytic killing of bacteria. The toxin
penetrates myeloid phagocytes, such as neutrophil,
macrophage or dendritic cells, and subverts their signaling
by catalyzing a rapid and massive conversion of intracel-
lular ATP to the key signaling molecule cAMP. In parallel,
the toxin forms cation-selective pores and permeabilizes
the cytoplasmic membrane of phagocytes. This so-called
‘hemolysin’ activity synergizes with the enzymatic AC
activity of CyaA in promoting apoptotic or necrotic cell
death, depending on the toxin dose. Moreover, the pore-
forming activity promotes activation of NALP3 inflamma-
some and release of interleukin IL-1b. We show here that
the capacity of CyaA to permeabilize phagocytes depends
on its ability to mediate influx of extracellular calcium ions
into cells. This enables bystander CyaA pores to escape
rapid macropinocytic removal from cell membrane and
exacerbate the permeabilization of cells. These observa-
tions set a new paradigm for the mechanism of action of
pore-forming RTX leukotoxins on phagocytes.
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documented in Figure 1C and Figure 1E.
To characterize the differing uptake pathways, we next
examined the co-localization of the toxoids with transferrin, a
marker of clathrin-dependent endocytosis [22]. As shown by
representative images in Figure 2A and quantified by Pearson’s
correlation coefficients (P.c.c.) for compared channels in Figure 2B,
the co-localization of dCyaA with transferrin (Dyomics 547)
increased in time and was near-complete after 60 minutes of co-
incubation with cells. In contrast, a weak and progressively
Figure 1. dCyaA-KP toxoid unable to promote calcium influx and relocate into lipid rafts is rapidly taken up by J774A.1 cells. (A)
J774A.1 cells were loaded with the calcium probe Fura-2/AM at a 3 mM final concentration at 25uC for 30 min. After washing in HBSS medium, toxoid
variants (3 mg/ml) or buffer were added at time zero (indicated by arrow) and time course of calcium entry into cytosol of cells (elevation of [Ca
2+]i)
was followed by spectrofluorimetry [14]. (B) J774A.1 cells were incubated for 10 minutes with 500 ng/ml of dCyaA or dCyaA-KP and detergent-
resistant membrane microdomains (DRMs) were extracted with cold Triton X-100, separated by flotation in sucrose density gradient and probed in
Western blots with the 9D4 antibody. The DRM fractions were defined as fractions enriched in the lipid raft marker NTAL. The transferrin receptor
CD71 was used as a non-raft marker that remained in the bottom fractions of the gradient. (C) J774A.1 cells grown on glass bottom microwell dishes
were incubated for 20 minutes at 37uC with 5 mg/ml of Dyomics 647-labeled dCyaA or Alexa Fluor 488-labeled dCyaA-KP proteins in the presence or
absence of the anti-CD11b MAb M1/70 (20 mg/ml). Endocytic uptake of toxoids was analyzed at indicated time points by live cell imaging using an
Olympus Cell
R IX 81 microscope with a 606/1.35 oil objective (UPlanSApo). (D) The numbers of endosomes localized in cytoplasm of cells and loaded
with dCyaA or dCyaA-KP were counted as described in detail in the legend to Supplementary figure S2, using a script based on WCIF ImageJ software
(http://rsb.info.nih.gov/ij, http://www.uhnresearch.ca/facilities/wcif/imagej). The plot shows mean values plus standard deviations, as calculated on
20 to 40 cells per time point for one representative experiment out of three performed (n=3). (E) J774A.1 cells (3610
5) were incubated for 30 min on
ice at three different toxoid concentrations within the linear range of the dose-response curve (0.5, 1 and 5 mg/ml) and in the presence or absence of
the anti-CD11b monoclonal antibody M1/70 (20 mg/ml, 15 min of preincubation of cells). Binding to cells was assessed as cell-associated toxoid
fluorescence by FACS analysis. The % of toxoid binding at each concentration was calculated, taking the value for dCyaA toxoid in the absence of M1/
70 as 100%. The average 6 standard deviations are shown.
doi:10.1371/journal.ppat.1002580.g001
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observed over the same time interval. Hence, while dCyaA was
transiting through the early and/or recycling compartment
together with transferrin, the dCyaA-KP toxoid took a different
pathway.
To corroborate this observation, the uptake of the two toxoids
was examined in RAW 264.7 macrophages expressing a dominant
negative variant of the EPS-15 protein (DN EPS-15-GFP, DIII),
which selectively interferes with clathrin-dependent endocytosis
[23]. As documented by a representative image in Figure 2C (left),
the accumulation of transferrin and dCyaA at intracellular sites
was abrogated in DN EPS-15-GFP-transfected cells (blue) and no
co-localization of cell-associated dCyaA with transferrin was
observed upon removal of surface-associated transferrin with a
low pH buffer wash. As further documented by the z-axis
projections, few if any intracellular vesicles containing dCyaA were
observed inside DN EPS-15-GFP-transfected cells and the
membrane-associated dCyaA was located exclusively inside
fluorescent patches on cell surface. In striking contrast, the
endocytic uptake of dCyaA-KP was unaffected in DN EPS-15-
GFP-transfected cells and intracellular vesicles containing dCyaA-
KP were clearly observed in the z-axis projections (Figure 2C,
right panel). Neither of the two toxoids exhibited any co-
localization with caveolin-1 (Figure S3). By difference to dCyaA,
however, the dCyaA-KP exhibited a strong co-localization with
soluble fluorescent BSA serving as a fluid phase uptake marker. As
also shown in Figure 3C and quantified in Figure 3D, the kinetics
of dCyaA-KP endocytic uptake was strongly decelerated upon
pretreatment of cells with wortmannin (1 mM), a PI3 kinase
inhibitor blocking macropinocytosis but not micropinocytosis [24].
In contrast, no inhibition of dCyaA-KP uptake was observed upon
treatment with dynasore or chlorpromazine, the inhibitors of
clathrin-dependent endocytosis [25,26]. It can, hence, be con-
cluded that dCyaA was endocytosed through a decelerated
clathrin-dependent pathway, while dCyaA-KP was internalized
with the cytoplasmic membrane by a macropinocytic mechanism.
Figure 2. Intact dCyaA toxoid is endocytosed by a clathrin-dependent mechanism. (A) J774A.1 cells were incubated for 20, 40 and
60 minutes with 1 mg/ml of Alexa Fluor 488-labeled dCyaA or dCyaA-KP. For simultaneous visualization of early and recycling endocytic
compartments, cells were co-incubated at 37uC for the last 20 minutes with Dyomics 547-labeled transferrin (10 mg/ml). Cells were washed in cold
PBS, fixed with 4% PFA, and observed using a Leica confocal microscope TCS SP2 with a 636/1.40 oil objective (HCX PL APO). (B) Co-localization of
toxoids with transferrin was quantified using ImageJ software as described in details in Materials and Methods. (C) Murine RAW 264.7 macrophages
transfected by dominant-negative mutant (DIII) of Eps-15 protein fused to GFP (blue) were incubated at 37uC for 30 min with the dCyaA or dCyaA-KP
toxoids (1 mg/ml) labeled with Dyomics-647 (green). Dyomics 547-labeled transferrin (10 mg/ml) was added for the last 10 minutes of incubation
(red), cells were washed with 0.1 M sodium acetate, 150 mM NaCl, pH 3.5 to remove surface-associated transferrin, fixed and observed with Olympus
CellR microscope using a 1006oil immersion objective (N.A. 1.3). The calculated values of Pearson’s correlation coefficients for transferrin (Dyomics
547) and toxoid (Dyomics 647) in non-transfected cells were 0.319 and 0.067 for dCyaA and dCyaA-KP, respectively.
doi:10.1371/journal.ppat.1002580.g002
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and reduced delivery of antigenic cargo for MHC II-
restricted presentation
Clathrin-dependent endocytosis was previously shown to enable
dCyaA-mediated delivery of model antigens into CD11b
+
dendritic cells for endosomal processing and MHC class II-
restricted presentation to CD4
+ T cells [18]. Therefore, we
examined whether altered endocytic trafficking affected the
antigen delivery capacity of the dCyaA-KP toxoid.
As documented in Figure 4A and quantified in Figure 4B,
following one hour of incubation with RAW 264.7 macrophages
expressing Rab-7-EGFP, fluorescently labeled material derived from
either of the toxoids accumulated within organelles positive for the
lysosomal/late endosomal marker Rab7. dCyaA and dCyaA-KP
toxoid-derived fluorescence also co-localized to the same extent with
the MHC II–EGFP molecules in a subset of intracellular vesicles of
bone marrow derived dendritic cells from a MHC Class II–EGFP
knock-in mice, within 120 minutes of incubation (Figure 4C, 4D).
Despite entering cells by different endocytic pathways, hence, the
two toxoids or their fragments reached similar acidic endosomes.
To test if faster macropinocytic uptake lead to alteration of
dCyaA-KP processing, lyzates from toxoid-pulsed J774A.1 cells
were probed in Western blots with the 9D4 MAb that recognizes
C-terminal RTX repeats of CyaA. As shown in Figure 5A,
comparable amounts of the ,200 kDa forms of both toxoids and
of their fragments were detected in lyzates of cells pretreated with
inhibitors of endocytosis and protease inhibitors, like 0.01%
sodium azide plus 10 mM 2-deoxy glucose (2DG), or a protease
inhibitor cocktail plus 1 mM chloroquine. As compared to dCyaA,
however, a notably faster degradation dCyaA-KP occurred in
uninhibited cells (Figure 5A), as judged from the detected amounts
of smear corresponding to partially digested molecules. dCyaA-KP
toxoid, hence, appeared to be degraded faster and more
completely, albeit the final protease-resistant fragments of both
toxoids appeared to be of similar size.
To examine if fasteruptake and degradationaffectedthe capacity
of dCyaA-KP to deliver cargo epitopes for endosomal processing
and MHC II-restricted presentation, the relative capacity of the two
toxoids to deliver CD4
+ T cell epitopes was assessed. As shown in
Figure 5B by comparison to dCyaA, the dCyaA-KP toxoid
Figure 3. Inactive dCyaA-KP toxoid is endocytosed by a rapid macropinocytic pathway. (A) J774A.1 macrophages were incubated with
BSA-Dyomics 547 (50 mg/ml) together with Alexa Fluor 488-labeled dCyaA or dCyaA-KP (1 mg/ml), respectively. After 10 and 30 minutes, the cells were
washed, fixed and observed as above. (B) Co-localization of toxoids with BSA was quantified using ImageJ software as described in details in Materialsa n d
Methods. (C) J774A.1 cells were incubated for 30 minutes in HBSSwithwortmannin (1 mg/ml),dynasore(40 mM) or chlorpromazine (5 mg/ml), before 5 mg/
ml of Alexa Fluor 488-labeled dCyaA-KP was added and time course of toxoid uptake was followed by live cell imaging and (D) quantified as above (n=3).
doi:10.1371/journal.ppat.1002580.g003
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epitope for presentation by BMDCs to CRMC3 CD4
+ T
hybridoma cells [27]. To corroborate this observation, the MalE
epitope was replaced by the OVA258–276 epitope recognized by
MF2.2D9 CD4
+ T hybridoma and new dCyaA and dCyaA-KP
toxoidswereproduced. As shown in Figure 5C, however, a similarly
reduced capacity to deliver the OVA258–276 epitopes for MHC II-
restricted presentation was again observed with dCyaA-KP, as
compared to dCyaA. This suggested that faster proteolytic
destruction of the cargo epitope during trafficking through the
macropinocytic-like pathway may have accounted for the reduced
efficacy of dCyaA-KP in antigen delivery.
Permeabilization of cells for calcium prevents rapid
macropinocytic removal of the toxoid from cell
membrane
To test whether the loss of capacity to mediate influx of Ca
2+
ions into cells committed dCyaA-KP for the rapid macropinocytic
uptake and subsequent degradation, the J774A.1 cells were
incubated with dCyaA-KP in the presence of ionomycin, a
calcium ionophore that permeabilizes cells for extracellular Ca
2+.
As documented in Figure 6A, Video S3, and as quantified in
Figure 6B, respectively, internalization of dCyaA-KP into
fluorescent intracellular vesicles was strongly delayed upon
treatment of J774A.1 cells with 5 or 10 mM ionomycin in the
presence of 1.9 mM Ca
2+. As also shown in Figure 6A (Video S4)
and quantified in Figure 6B and 6C, dCyaA-KP was redirected
into a slower uptake pathway even more efficiently upon co-
incubation at a 1:1 ratio with intact dCyaA. This goes well with
our previous observation that permeabilization of cells for Ca
2+ in
trans by intact dCyaA rescued in part the defect of a CyaA-KP
construct and mobilized it into lipid rafts [15]. Upon co-
incubation with dCyaA, a fraction of biotinylated dCyaA-KP
protein was indeed found to float in sucrose gradients with
detergent-resistant membrane (Figure 6D). Furthermore, follow-
ing co-incubation with dCyaA, the dCyaA-KP appeared to be
endocytosed with the same kinetics and through the same
pathway as the intact toxoid ( Videos S1 and S4). The two
Figure 4. Both toxoids end up in MHC II-positive organelles. Transfected RAW 264.7 macrophages expressing Rab-7-EGFP were incubated for
60 minutes with Dyomics 647-labeled toxoids (1 mg/ml), washed, fixed and analyzed by live cell imaging. (B) Co-localization of toxoids with Rab-7-
EGFP was quantified using ImageJ software. (C) Cells from MHC Class II/EGFP knock-in mice (green) were incubated at 37uC in DMEM without serum
for 2 hours with 1 mg/ml of Dyomics 647-labeled (red) dCyaA or dCyaA-KP. Cells were fixed in 4% PFA and mounted in Mowiol. Images were captured
using an inverted Olympus Cell
R microscope equipped with a 606/1.35 oil immersion objective (UPlanSApo). (D) Co-localization of toxoids with MHC
II/EGFP was quantified using ImageJ software.
doi:10.1371/journal.ppat.1002580.g004
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60 minutes of incubation with cells (Figure 6E, 6F). Hence,
permeabilization of cells for Ca
2+ by ionomycin or intact toxoid
rescued dCyaA-KP from the rapid macropinocytic membrane
uptake pathway and redirected it for decelerated and clathrin-
dependent endocytosis.
Calcium-induced deceleration of endocytic removal from
plasma membrane enables CyaA hemolysin pores to
permeabilize phagocytes
We have previously observed that the CyaA-DAC hemolysin
construct lacking the AC domain of CyaA (D1–373) was unable to
promote Ca
2+ influx into monocytes and was essentially unable to
Figure 5. Macropinocytosed dCyaA-KP toxoid is rapidly degraded and its capacity to deliver epitopes for presentation on MHC
class II molecules is compromised. (A) 10
6 J774A.1 cells were preincubated for 30 minutes at 37uC in 1 ml of D-MEM medium alone, or in D-MEM
containing 1 mM chloroquine plus a cocktail of protease inhibitors (Complete Mini, Roche), or in D-MEM containing 10 mM 2DG and 0.01% of sodium
azide, respectively. dCyaA or dCyaA-KP toxoids were added to a final concentration of 1 mg/ml and after continued incubation the cells were washed
three times in ice-cold D-MEM at the indicated times and lyzed on ice during 30 minutes in TBS buffer containing 1% Triton X-100 and the protease
inhibitor cocktail (Complete Mini, Roche). Cell nuclei were removed by centrifugation at 13,000 RPM for 10 min and supernatants of lyzed cells were
separated by 7.5% SDS-PAGE. CyaA fragments were detected in Western blots using the 9D4 antibody recognizing the C-terminal RTX repeats of
CyaA. The arrow indicates migration of full-length (undegraded) 200 kDa CyaA. (B) BMDC from C57BL/6 mice were pulsed with indicated
concentrations of dCyaA or dCyaA-KP, or (C) with dCyaA-OVA258–276 or dCyaA-OVA258–276-KP and following medium disposal, the MalE-specific
hybridoma CRMC3 (B) or OVA258–276-specific hybridoma MF2.2D9 cells (C) were added, respectively. Secretion of IL-2 by antigen-stimulated CRMC3
hybridoma (B) was determined as proliferation of the IL-2-dependent CTL-L cell line and the results are expressed in cpm 6 SE of duplicate samples.
The concentration of IL-2 produced by MF2.2D9 cells upon antigenic stimulation (C) was determined by sandwich ELISA. A representative Western
blot from 3 independent experiments and the averaged values from two independent antigen presentation experiments performed in duplicates
(n=4), are shown.
doi:10.1371/journal.ppat.1002580.g005
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bilayers, or on sheep erythrocytes devoid of endocytic mecha-
nisms, the CyaA-DAC hemolysin exhibited the same specific pore-
forming and hemolytic activities as the full-length dCyaA (CyaA-
AC
2) [4]. We thus hypothesized that its inability to lyze J774A.1
cells might be due to rapid removal of the CyaA-DAC pores from
the cytoplasmic membrane of J774A.1 cells. As shown in
Figure 7A, the CyaA-DAC hemolysin elicited much slower efflux
of cytosolic K
+ from J774A.1 cells then the full-length toxoid. In
cells exposed to 3 mg/ml of enzymatically inactive CyaA-AC
2 a
complete drop of cytosolic [K
+]i concentration down to 10 mM
was reproducibly observed within 20 minutes, while in cells
exposed to equal amounts of CyaA-DAC the [K
+]i only decreased
to 80 mM (Figure 7A).
To determine if this was due to rapid removal of CyaA-DAC
pores from cell membrane, we assessed the capacity of CyaA-DAC
to elicit K
+ efflux on cells with membrane trafficking inhibited
upon preincubation in media containing 0.01% (w/w) sodium
azide and 10 mM 2-deoxy-glucose (2DG). This treatment
potentiated the cell-permeabilizing activity of full-length CyaA-
AC
2 toxoid (Figure 7A, 7B), but did not promote any significant
K
+ efflux from cells on its own despite causing an about five-fold
drop of cellular ATP levels (Figure 7A, 7B and 7C). As further
documented in Figure 7E and 7F (Videos S5 and S6), the strong
inhibition of the CyaA-DAC uptake was accompanied by a steep
increase of the specific capacity of CyaA-DAC to promote K
+
efflux (Figure 7A and 7B) from cells and lyze J774A.1 monocytes
(Figure 7D). It can thus be concluded that rapid macropinocytic
internalization with cell membrane was strongly restricting the cell
permeabilizing and cytolytic capacities of the CyaA-DAC
hemolysin pores.
As further shown in Figure 7G, despite the prolonged
persistence in the cytoplasmic membrane of cells upon inhibition
of endocytosis, the CyaA-DAC hemolysin failed to associate with
lipid rafts (compare CyaA-DAC panel in Figure 7G and upper
dCyaA panel of Figure 1B for comparable toxoid loading). This
goes well with our previous observation that mobilization into lipid
rafts with CD11b/CD18 depends on the capacity of CyaA to
conduct calcium ions into cells to activate talin cleavage by calpain
[15]. More importantly, this result shows that CyaA pores can
form outside of lipid rafts within the bulk phase of cell membrane.
We next tested if Ca
2+ influx induced in trans would delay
removal of CyaA-DAC from cytoplasmic membrane and extend
thereby its capacity to permeabilize J774A.1 cells. Mobilization of
Ca
2+ into cells with ionomycin, however, caused on its own a high
unspecific leakage of K
+ from J774A.1 cells (data not shown).
Therefore, an alternative approach was used, exploiting the
capacity of the 3D1 MAb to lock CyaA molecules in the
conformation of membrane-inserted ‘translocation precursors’
that conduct calcium ions across the cytoplasmic membrane of
cells [15]. CyaA-DAC was preincubated with 3D1, or with an
isotype control IgG1 MAb (TU-01, 20 mg/ml) and the capacity of
the CyaA-DAC to elicit K
+ efflux from J774A.1 cells was assessed.
As documented in Figure 8A, while the 3D1 MAb alone did not
cause any elevation of [Ca
2+]i, the binding of 3D1 conferred on
CyaA-DAC the capacity to promote rapid influx of Ca
2+ into
monocytes. As shown in Figure 8B, this allowed association of
detectable amounts of CyaA-DAC molecules with lipid rafts. More
importantly, the capacity of CyaA-DAC to permeabilize J774A.1
cells for K
+ efflux was strongly enhanced in the presence of 3D1
MAb and equaled the specific cell-permeabilizing activity of the
intact and enzymatically active CyaA, as shown in Figure 8C and
8D. Furthermore, this enhancement of cell-permeabilizing activity
was accompanied by a strong deceleration of endocytic uptake of
CyaA-DAC (Figure 8E, 8F).
To test the hypothesis that toxoid-induced K
+ efflux itself
contributed further deceleration of endocytosis, the clathrin-
mediated uptake of dCyaA was examined in media supplemented
with 50 mM potassium ions. As documented in Figure 9A and
quantified in Figure 9B, the endocytosis of dCyaA was clearly
accelerated when efflux of K
+ from cells was counteracted by
addition of potassium ions into media. Collectively, hence, these
results show that CyaA-mediated Ca
2+ influx rescues hemolysin
pores from rapid macropinocytic uptake from cell membrane and
thus extends their cell-permeabilizing and cytolytic action.
Endocytosis controls also the cytolytic potency of
enzymatically active CyaA
The pore-forming activity was previously shown to synergize
with the ATP-depleting and cAMP-signaling activities of the cell-
invasive AC domain of CyaA [8,9]. Therefore, we examined to
which extent does endocytic uptake modulate the cytotoxicity of
fully active (AC
+) toxin.
We assessed first the impact of cAMP accumulation on the
uptake of CyaA, using a fluorescently labeled CyaA-KP construct
(AC
+) that exhibits only a residual capacity to deliver the AC
enzyme into cells. Unlike active toxin, hence, CyaA-KP does not
provoke cell death at the high concentrations (1 to 5 mg/ml)
employed in live cell imaging. As shown in Figure 10A, at such
concentrations the dCyaA-KP produced easily detectable cAMP
amounts in cells, while the extent of its endocytic uptake was the
same as that of the enzymatically inactive (AC
2) dCyaA-KP
toxoid (Figure 10B, 10C). Since both proteins were unable to
mediate detectable Ca
2+ influx into J774A.1 cells (ref. [15] and
Figure 1B), it can be concluded that cAMP levels alone do not
noticeably influence the rate of endocytic uptake of CyaA.
It was next important to characterize the rate of endocytic
uptake of CyaA at as low toxin concentrations as that presumably
encountered by host phagocytes during Bordetella infections.
Therefore, the kinetics of CyaA endocytosis by J774A.1 cells was
assessed by a flow cytometry assay measuring the amount of
biotinylated CyaA that remains accessible to binding by
streptavidin on cell surface. As shown in Figure 11, pulsing of
J774A.1 cells for 5 minutes at 37uC with 200 ng/ml of CyaA-
biotin yielded about 1 ng of toxin stably bound to 3610
5 washed
cells, when kept on ice. In contrast, the amounts of surface-
exposed CyaA-biotin decreased progressively upon transfer of cells
to 37uC, with ,80% of CyaA being removed from cell surface
Figure 6. Calcium influx into J774A.1 macrophages decelerates endocytic uptake of the dCyaA-KP toxoid. (A) J774A.1 cells were
incubated for 20 minutes at 37uC with 5 mg/ml of Dyomics 647-labeled dCyaA-KP alone, or in the presence of ionomycin (5 mM and 10 mM), or as a
1:1 mixture with Alexa 488-labeled dCyaA. (B) Uptake of toxoids into cells was analyzed by live cell imaging as above and (C) P.c.c. values for the
mixed sample of dCyaA and dCyaA-KP were calculated. (D) J774A.1 cells were incubated for 10 minutes with 500 ng/ml of dCyaA, dCyaA-KP-biotin or
with 1:1 mixture of dCyaA and dCyaA-KP-biotin toxoids. Detergent-resistant membrane microdomains (DRMs) were extracted, separated and probed
as in Figure 1B. Biotin-labeled dCyaA-KP was detected with streptavidin HRP conjugate (GE Healthcare, Chalfont St. Giles, UK). (E) Transfected RAW
264.7 macrophages expressing Rab-7-EGFP were incubated for 30 and 60 minutes with 1 mg/ml of Dyomics 547 (dCyaA) and Dyomics 647-labeled
toxoids (dCyaA-KP), washed, fixed and analyzed fluorescence imaging and (F) P.c.c. values were determined as in Figure 4.
doi:10.1371/journal.ppat.1002580.g006
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PLoS Pathogens | www.plospathogens.org 9 April 2012 | Volume 8 | Issue 4 | e1002580Figure 7. Rapid removal from the plasma membrane reduces toxoid-mediated K
+ efflux from monocytes. (A) PBFI/AM loaded J774A.1
monocytes in HBSS buffer were exposed to 3 mg/ml of enzymatically inactive CyaA-AC
2 toxoid, or to its CyaA-DAC variant, and K
+ efflux at 25uC was
monitored in time as described under Materials and Methods. (B) PBFI/AM loaded J774A.1 macrophages were preincubated for 15 minutes in HBSS
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biotin uptake was reduced by about a factor of two in the presence
of a 5-fold (non-saturating) excess of unlabeled CyaA-AC
2 toxoid
(1 mg/ml) that enhanced Ca
2+ influx and K
+ efflux across the
membrane of J774A.1 cells [14].
To address the relative contribution of cell surface retention of
CyaA pores to the overall cytotoxic potency of low amounts of
intact (AC
+) CyaA, the natively fatty-acylated Bp-CyaA purified
from B. pertussis 18323/pHSP9 was used [28]. Bp-CyaA exhibits
about fourfold higher specific pore-forming (hemolytic) activity
than the recombinant rEc-CyaA produced in E. coli ([11] and
Figure S4). Therefore the use of Bp-CyaA allowed maximizing the
observable amplitude of changes in cell permeabilizing and
cytolytic capacity that would result from alterations of the rate
of toxin pore removal from cell membrane. As indeed shown in
Figure 12, as little as 100 ng/ml of Bp-CyaA promoted a
detectable LDH release form J774A.1 cells already in 2 hours of
incubation. Inhibition of endocytic uptake of Bp-CyaA with 2DG
and sodium azide treatment then increased the cytolytic potency
of Bp-CyaA by a factor of 2 to 3 (Figure 12A) and strongly
increased the capacity of Bp-CyaA to permeabilize cells for K
+
efflux, which become well observable already at 300 ng/ml of the
toxin (Figure 12B).
Discussion
We show here that by conducting Ca
2+ ions across target cell
membrane, CyaA decelerates its endocytic uptake and escapes
from rapid macropinocytic removal from cell membrane and
destruction in endosomes. By redirecting the toxin into a
decelerated clathrin-dependent uptake pathway, the calcium-
conducting activity of toxin translocation intermediates protracts
toxin pore persistence within cytoplasmic membrane, thus
extending phagocyte permeabilization and maximizing cytotoxic
action of CyaA, as summarized in the model proposed in
Figure 13.
This mechanism could be directly demonstrated here for the
CyaA-AC
2 toxoid and CyaA-DAC hemolysin variants that lack
the AC enzyme activity and could be used at sufficiently high
concentrations for live cell imaging. Imposing on CyaA-DAC a
conformation that enabled it to conduct Ca
2+ into cells, indeed,
rescued the hemolysin from the macropinocytic pathway, and by
decelerating its removal form cell membrane, it particularly
enhanced the otherwise very low cell-permeabilizing and cytolytic
capacity of CyaA-DAC.
Using intact toxin (AC
+) purified form B. pertussis cells at close to
physiologically relevant concentrations (200 ng/ml), we found that
inhibition of endocytic uptake of Bp-CyaA enhanced its capacity to
lyze cells. It was, however, not possible to design an experiment
that would directly prove the role of calcium-induced deceleration
of CyaA uptake in its cytotoxic action. Such demonstration would
only be possible if inhibition of Ca
2+ influx would leave the other
cytotoxic activities of CyaA unaffected. This would then allow to
test whether cytolytic activity of CyaA is reduced by acceleration
of the endocytic uptake of the intact toxin. However, Ca
2+ influx
into cells is a prerequisite for CyaA relocation into lipid rafts and
subsequent AC domain translocation into cell cytosol [15].
Therefore, blocking of Ca
2+ influx by whatever means inevitably
ablates also the major component of the cytotoxic activity of
CyaA, namely the capacity of its AC enzyme to reach cell cytosol
and catalyze unregulated dissipation of cytosolic ATP into cAMP
to impair cellular signaling.
We have previously shown that upon initial binding of the
CD11b/CD18 integrin, the CyaA toxin inserts into the
membrane lipid bilayer as a translocation precursor, in which
the segments of the AC domain cooperate with segments of the
pore-forming domain in forming a novel calcium-conducting
path across the phagocyte membrane that mediates influx of
extracellular Ca
2+ ions into cells [14,15]. Activation of calpain by
incoming Ca
2+ then yields cleavage of the talin tether of CD11b/
CD18 and liberates the toxin-receptor complex for recruitment
into membrane lipid rafts [15]. This process appears to be
entirely independent of the cAMP-generating capacity of CyaA
in CD11b
+ J774A.1 macrophage cells, as a quite comparable
amplitude and even faster initial kinetics of calcium mobilization
into cells is observed with the enzymatically inactive dCyaA
variant (CyaA-AC
2) than by intact CyaA [14,15]. The results
presented in this study then show that it is rather the
permeabilization of cells for influx of Ca
2+, than the toxin
relocation into lipid rafts itself, which allows the toxoid to escape
the rapid macropinocytic removal from cell surface with the
cytoplasmic membrane. Moreover, lipid rafts are tiny micro-
domains in the membrane that would accommodate only limited
amounts of the hemolysin, while a quantitative escape from
rapid macropinocytosis of dCyaA-KP toxoid and its redirection
for decelerated endocytosis was observed upon co-incubation
with dCyaA (Figure 6A). This indicates that by permeabilizing
cells for calcium influx, the AC-translocating CyaA conformers
provoke also deceleration of endocytosis of the bystander CyaA
pores that can form outside the rafts, in the bulk phase of cell
membrane.
Such conclusion would also be in line with the observed
opposing phenotypes of the CyaA-E509K+516K (CyaA-KK) and
CyaA-E570Q+K860R (CyaA-QR) variants of CyaA. While the
CyaA-KK exhibits a strongly enhanced specific pore-forming
activity, its capacity to promote Ca
2+ influx into cells is very low
[14,29]. On the opposite, the CyaA-QR toxin exhibits a very low
capacity to form pores, to permeabilize cells and elicit K
+ efflux,
while it mediates normal levels of calcium influx into cells [6,15].
This suggests that K
+ efflux and Ca
2+ influx are two parallel and
independent processes that are associated with distinct conforma-
tional and/or oligomeric states of the two co-existing conformers
of membrane-inserted CyaA.
buffer containing 0.01% sodium azide and 10 mM 2DG prior to addition of CyaA-AC
2 or CyaA-DAC proteins and time course of K
+ efflux was
recorded. The shown curves are representative of six independent experiments. (C) 10
6 J774A.1 cells were incubated for 15 minutes in D-MEM or in
D-MEM containing the glycolysis inhibitor 2-deoxy-D-glucose (2DG, 10 mM) instead of glucose and 0,01% sodium azide. ATP content in cells was
determined using the ATP Bioluminescence Assay Kit CLS II (Roche). (D) Prior to addition of the CyaA-DAC protein, 2610
5 J774A.1 macrophages were
preincubated for 15 minutes at 37uC in D-MEM alone or in D-MEM medium without glucose and containing 0.01% sodium azide plus 10 mM 2DG.
The extent of cell lysis was determined using the Cytotox 96 assay kit (Promega) as the amount of lactate dehydrogenase released into culture media
in 2 hours. Average values from three independent experiments performed in duplicates are shown. (E) CyaA-DAC, in contrast to CyaA-AC
2 is rapidly
internalized into J774A.1 cells. J774A.1 cells were preincubated for 15 minutes in HBSS, or in glucose-free HBSS with 2DG and sodium azide, before
5 mg/ml of Fluor 488-labeled CyaA-DAC or CyaA-AC
2 were added. Toxoid endocytosis was analyzed by live cell imaging and (F) Numbers of
endosomes containing CyaA-DAC and CyaA-AC
2 were determined as above. (G) J774A.1 cells were preincubated for 15 minutes in HBSS or in HBSS
containing sodium azide and 2DG prior to addition of CyaA-DAC (500 ng/ml). Detergent-resistant membrane microdomains (DRMs) were extracted,
separated and probed as in Figure 1B.
doi:10.1371/journal.ppat.1002580.g007
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2+ decelerates macropinocytic uptake of CyaA-DAC and enables cell permeabilization by hemolysin pores. (A)
J774A.1 cells were loaded with Fura-2/AM and exposed to 3 mg/ml of CyaA-DAC (arrow) preincubated for 15 minutes at room temperature with 3D1,
or with the isotype control antibody TU-01 (20 mg/ml) and Ca
2+ influx was recorded. The shown curves are representative of three independent
experiments. (B) J774A.1 cells were exposed for 10 minutes at 37uC to CyaA protein variants (500 ng/ml) preincubated with 3D1 or TU-01 (20 mg/ml)
and cell lyzates were separated on sucrose density gradients as in Figure 1B. The 3D1 and isotype IgG1 mAbs were detected with anti-mouse IgG
antibody. (C) 3 mg/ml of CyaA-DAC or of CyaA (D) were preincubated with 3D1 or TU-01 (20 mg/ml), added to PBFI/AM loaded J774A.1 macrophages
and time course of K
+ efflux from J774A.1 was recorded. The curves are representative of four independent experiments. (E) J774A.1 cells were
exposed to 5 mg/ml of Alexa 488-labeled CyaA-DAC preincubated with 3D1 or TU-01 mAb (20 mg/ml). The time course of CyaA-DAC endocytosis was
followed by live cell imaging and (F) quantified.
doi:10.1371/journal.ppat.1002580.g008
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to CyaA-DAC exacerbated at the same time its capacity to
conduct calcium ions into cells, as well as its cell permeabilizing
c a p a c i t y .T h i sw o u l d ,p e r h a p s ,b eb e s te x p l a i n e db yt h e
bystander effect mentioned above. Due to association-dissocia-
tion equilibrium, the antibody would lock only a fraction of
membrane-inserted CyaA-DAC molecules into a calcium-
conducting conformation. The other fraction of hemolysin
molecules, not bound with 3D1, would hence be free to form
the cell-permeabilizing oligomeric pores promoting K
+ efflux,
benefiting from the calcium-induced deceleration of the
endocytic uptake of the hemolysin pores. It remains, neverthe-
less, to be conclusively shown that bridging of CyaA-DAC dimers
by the bivalent 3D1 antibody does not also contribute to the
enhanced cell permeabilization capacity and K
+ efflux mediated
by the CyaA-DAC hemolysin complexes with the antibody. 3D1
might, indeed, potentially stabilize the formed oligomeric pores
against dissociation within the membrane. At present it can
neither be formally excluded that the complex of membrane-
inserted CyaA-DAC with 3D1 might be conducting at the same
time the Ca
2+ ions into cells and the K
+ ions out of the cell. For
intact CyaA the accumulated evidence strongly argues against
such possibility (see above). Due to absence of the translocated
AC domain, however, the 3D1-locked conformers of CyaA-DAC
may be capable of oligomerization into pores enabling K
+ efflux,
or the calcium-conducting path formed by these conformers may
be accessible for efflux of cytosolic K
+ ions in the absence of the
AC domain.
A particularly intriguing observation is that the Ca
2+ influx and
K
+ efflux-promoting activities of the toxin synergize in manipu-
lating the pathway and kinetics of CyaA endocytosis. Indeed, the
decrease of intracellular potassium level was repeatedly shown to
cause inhibition of clathrin-mediated endocytosis [30,31]. Hence,
the more the cell becomes permeabilized for efflux of K
+, upon
inhibition of macropinocytic uptake of toxin pores by incoming
Ca
2+, the more the potassium leakage from cells through toxin
pores further decelerates the clathrin-dependent removal of CyaA
pores from cell membrane. Such cooperation of Ca
2+ influx and
K
+ efflux-mediating activities of CyaA would thus generate a
positive feedback loop, exacerbating potassium depletion due to
steadily increasing extent of cell membrane permeabilization by
persisting and/or newly forming CyaA pores.
Figure 9. Potassium efflux delays endocytosis of dCyaA toxoid. A) J774A.1 cells were incubated for 20 minutes at 37uC with 5 mg/ml of Alexa
488-labeled dCyaA in HBSS containing 5 mM KCl or in HBSS containing 50 mM KCl. Uptake of dCyaA into cells was analyzed by live cell imaging and
(B) numbers of endosomes in cell cytoplasm were quantified (n=3).
doi:10.1371/journal.ppat.1002580.g009
Figure 10. Endocytosis of CyaA is not affected by cAMP. (A) The capacity to translocate the AC domain across cytoplasmic membrane was
assessed as the capacity to elevate cytosolic concentrations of cAMP. J774A.1 cells were incubated with CyaA or CyaA-KP-Alexa 488 for 30 minutes at
37uC and the amounts of accumulated cAMP were determined in cell lyzates. The shown curves are representative of two independent experiments
performed in duplicates. (B) J774A.1 cells were incubated for 20 minutes at 37uC with 5 mg/ml of Alexa 488-labeled dCyaA-KP or CyaA-KP constructs,
the protein uptake was analyzed by live cell imaging and (C) the numbers of endosomes in cytoplasm were quantified as above.
doi:10.1371/journal.ppat.1002580.g010
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was apparently operating under the used experimental conditions,
since vesicles containing dCyaA were observed to accumulate as
tightly attached to, or located just beneath the cell membrane, for
over 20 minutes from toxoid addition (Figure 1 and Video S1).
This shows that excision of clathrin-coated vesicles from cell
membrane was inhibited and protraction of cell membrane
permeabilization by the persisting pores then fed back into
deceleration of endocytic uptake of dCyaA.
The enzymatically active CyaA could not be used in this study
for analysis of endocytic trafficking of CyaA by live cell microscopy
imaging, as at the high concentrations of labeled proteins (.1 mg/
ml), required for this type of analyzes, the enzymatically active
CyaA uncontrollably impairs intracellular trafficking by rapid
depletion of ATP and induction of cell death [8,9]. Indeed, the
cytotoxic action of enzymatically active CyaA on CD11b
+
phagocytes was documented repeatedly at doses lower than
10 ng/ml, where less than 1 ng/ml of active CyaA toxin
quantitatively inhibits oxidative burst in neutrophils [32]. As low
CyaA doses as 5 to 10 ng/ml elicit monocyte ruffling and a near-
instant inhibition of CR3-mediated opsonophagocytosis or arrest
of the fluid-phase uptake, respectively. This appears to be due to
cAMP signaling-mediated inhibition of the small GTPase RhoA
and possibly of the PI3 kinase [21]. The results obtained here with
the toxoids appear, nevertheless, to be relevant also to the
understanding of endocytosis and of cytotoxic action of the
enzymatically active CyaA. By using a newly developed FACS
assay for cell surface accessibility of bound CyaA, we could
approach here the kinetics of endocytic removal of intact CyaA
from cell surface at close to physiologically low toxin concentra-
tions (200 ng/ml). Under such conditions, the receptor-bound
CyaA was found to be progressively removed from cell surface
over 15 minutes of incubation with about one quarter of toxin
molecules escaping the uptake into endosomes and remaining
exposed on the surface of cell membrane. This endocytic uptake of
intact CyaA from cell membrane was noticeably slowed down in
the presence of a five-fold excess of enzymatically inactive CyaA-
AC
2 molecules that promoted Ca
2+ influx into cells and K
+ efflux
in trans. Moreover, inhibition of the endocytic uptake through
inhibition of ATP re-synthesis strongly enhanced the capacity of
native Bp-CyaA toxin to permeabilize and lyze cells already at as
low toxin concentrations as 200 ng/ml. This points towards a
more important contribution of the pore-forming activity to the
overall cytotoxic action of CyaA than previously recognized [8,9].
Enzymatically inactive but pore-forming CyaA-AC
2 toxoids
have been extensively used over the past 18 years for delivery of
AC-inserted CD8
+ and CD4
+ T cell epitopes from viruses,
mycobacteria or tumors into the MHC class I and II-restricted
antigen presentation pathways of CD11b-expressing dendritic cells
[33–36]. As dCyaA-based vaccines for cancer immunotherapy are
currently in phase I of clinical studies (www.genticel.com), the here
Figure 11. Ca
2+ influx and K
+ efflux promoted in trans
decelerate the endocytic uptake of enzymatically active CyaA.
J774A.1 macrophages (3610
6/ml) in D-MEM medium were incubated
for 5 minutes at 37uC with 200 ng/ml of rEc-CyaA-biotin, washed in D-
MEM and further incubated at 4uCo r3 7 uC, respectively, in the presence
or absence of 1 mg/ml of unlabeled CyaA-AC
2. At indicated time points
cell-surface localized rEc-CyaA-biotin per 3610
5 cells was detected with
PE-conjugated Streptavidine (0.5 mg/ml) by FACS analysis (n=3).
doi:10.1371/journal.ppat.1002580.g011
Figure 12. Endocytic removal from cell membrane controls the cytolytic potency of CyaA toxin. (A) 2610
5 J774A.1 macrophages were
preincubated for 15 minutes in D-MEM medium alone or in D-MEM without glucose containing 0.01% sodium azide and 10 mM 2DG prior to
addition of Bp-CyaA purified from B. pertussis 18323/pHSP9. The extent of cell lysis was determined as the amount of lactate dehydrogenase released
into culture media in 2 hours, using the Cytotox 96 assay kit (Promega). The results represent the average of values obtained in three independent
experiments performed in duplicates. (B) PBFI/AM-loaded J774A.1 macrophages were preincubated for 15 minutes in HBSS alone, or in HBSS buffer
without glucose but containing 0.01% sodium azide and 10 mM 2DG. K
+ efflux was monitored upon addition of 300 ng/ml of Bp-CyaA and the
shown curves are representative of three independent experiments.
doi:10.1371/journal.ppat.1002580.g012
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way towards deciphering of the efficacy of T cell vaccine delivery
by CyaA toxoids. Moreover, an endotoxin-free CyaA-AC
2
(dCyaA) toxoid was recently observed to alter the expression
levels of a dozen of genes involved in innate immune response
signaling in bone marrow-derived macrophages [37]. This is likely
due to the capacity of the toxoid to promote Ca
2+ influx into cells
and permeabilize cells for K
+ efflux. A long-sought evidence for a
role of the pore-forming capacity of CyaA in Bordetella pertussis
infection has, indeed, been recently reported by Dunne and
coworkers [29]. This study showed that by eliciting K
+ efflux from
dendritic cells, and perhaps some other CD11b-expressing
phagocytes, the pore-forming activity of CyaA contributes to
activation of the NALP3 inflammasome and thereby to induction
of innate IL-1b response, which supports the clearance of Bordetella
bacteria at later stages of infection. The results reported herein
show that the capacity of CyaA to permeabilize cells for K
+ efflux
depends on the capacity of the toxin to promote Ca
2+ influx into
cells and escape the rapid macropinocytic removal from target cell
membrane. This reveals a further layer of sophistication of CyaA
action on host cells, thus underpinning the key role of this toxin
with multiple ‘talents’ in the virulence of Bordetellae in mammals.
Materials and Methods
Antibodies and reagents
Mouse monoclonal antibody (MAb) anti-CD71 (clone MEM-
189) was from Exbio (Vestec, Czech Republic), anti-NTAL MAb
Figure 13. Model of the calcium influx-triggered positive feedback mechanism of self-exacerbating potassium efflux due to
protracted cell permeabilization by toxin pores. Upon binding to the aMb2 integrin (CD11b/CD18), the pore precursor conformers of dCyaA
oligomerize within the bulk phase of target cell membrane and permeabilize cells for efflux of cytosolic potassium ions. In parallel, toxin translocation
precursors insert into cellular membrane and conduct extracellular Ca
2+ into cell cytosol. Elevation of [Ca
2+]i in the submembrane compartment
results in activation of talin cleavage by calpain and liberates the receptor with bound toxin translocation precursor within target membrane for
lateral relocation into lipid rafts, where the translocation of the AC domain across plasma membrane is completed [15]. The entry of Ca
2+ provokes
deceleration of clathrin-dependent endocytic uptake of CyaA, thereby delaying removal of toxin pores from the cytoplasmic membrane. Protracted
persistence of CyaA pores within cellular membrane then triggers a self-amplifying (positive) feedback loop mechanism that exacerbates cell
permeabilization. The more potassium leaks out form cells, the more the clathrin-dependent endocytic removal of toxin pores from cellular
membrane is decelerated and the more is the cell permeabilization and potassium leakage exacerbated. In contrast, the mutated dCyaA-KP and the
CyaADAC hemolysin variants of CyaA are unable to conduct calcium ions into cells and are thus rapidly removed from the cytosolic membrane of
cells by a membrane macropinocytosis mechanism that directs the mutant toxoids for rapid proteolytic degradation.
doi:10.1371/journal.ppat.1002580.g013
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(Institute of Molecular Genetics, Prague, Czech Republic) and
anti-CyaA MAbs clone 9D4 and 3D1 were kindly provided by
Erik L. Hewlett (University of Virginia School of Medicine,
Charlottesville, USA). Fura-2/AM, PBFI/AM, Alexa Fluor 488,
LysoTracker-red DND-99, DAPI (49-6-diamidino-2-phenylindole)
and Mowiol were purchased from Molecular Probes (Eugene,
OR). Transferrin coupled to Dyomics 547, BSA-Dyomics 547 and
mouse monoclonal antibody against a-tubulin (TU-01, IgG1
isotype control) were from Exbio (Vestec, Czech Republic).
Ionomycin, valinomycin, nigericin, wortmannin, chlorpromazine,
dynasore, 2-deoxy-D-glucose, sodium azide, chloroquine and
Pluronic F-127 were purchased from Sigma (St. Louis, MO).
Complete Mini protease inhibitors cocktail was purchased from
Roche (Basel, Switzerland). NHS-Sulfo-LC-Biotin was purchased
from Pierce (Rockford, IL, USA). The SIINFEKL peptide
corresponding to the CD8
+ T-cell epitope encompassing the
chicken ovalbumin (OVA) residues 257–264 and to the CD4
+ T-
cell epitope NGKLIAYPIAVEALS peptide corresponding to the
Escherichia coli MalE protein (residues 100–114 [18]), respectively,
were purchased from Neosystem (Strasbourg, France).
Construction, production and purification of CyaA-
derived proteins
Construction of dCyaA was described earlier [18]. dCyaA-
OVA258–276, harboring the VQLTGLEQLESIINFEKLTEWTSS
NVMEERKIKVYLPRIVH peptide from hen egg ovalbumin
protein (OVA, residues 249–284) and carrying the MHC Class II
sequence IINFEKLTEWTSSNVMEER (OVA258–276) was con-
structed according to the standard protocols by insertion of a
corresponding double-stranded synthetic oligonucleotide between
codons 107 and 108 of the cyaA gene (Holubova et al., Infect.
Immun. doi:10.1128/IAI.05711-11, published online ahead of
print on 3 January 2012). The corresponding CyaA protein
variants, harboring the E570K and E581P substitutions, dCyaA-
KP and dCyaA-OVA258–276-KP were constructed by recombina-
tion with previously described plasmid constructs [18,38]. Toxoid
constructs were genetically detoxified by insertion of the dipeptide
sequence GlySer between residues 188 and 189, thus disrupting
the ATP binding site of the enzyme [39]. CyaA derivatives were
produced using E. coli strain XL1-Blue (Stratagene, La Jolla, CA)
in the presence of CyaC acyltransferase produced from the same
plasmid and were purified by chromatography on DEAE-
Sepharose and Phenyl-Sepharose as described earlier [40].
Enzymatically active CyaA (rEc-CyaA or CyaA) produced in E.
coli XL1-Blue and Bp-CyaA produced in B. pertussis strain 18323/
pHSP9 [28] were purified from urea extracts by combination of
chromatography on DEAE-Sepharose and calmodulin agarose.
All experiments were repeated with proteins from at least two
independent preparations.
Macrophage binding, cell lytic capacities and
determination of intracellular cAMP
J774A.1 macrophages (3610
5) were incubated in D-MEM with
200 ng/ml of CyaA-biotin for 5 min at 37uC, prior to removal of
unbound toxin by three washes in cold D-MEM medium. Cells
were lyzed with 0.1% Triton X-100 for determination of cell-
bound AC activity. Toxin-induced lysis of J774A.1 cells was
determined using the CytoTox 96 kit assay (Promega, Madison,
USA) as the amount of lactate dehydrogenase released from
2610
5 cells in 2 hours of incubation with CyaA at 37uCi nD -
MEM. 10
5 J774A.1 cells were incubated with different concen-
trations of the CyaA derived constructs for 30 minutes in D-MEM
medium without FCS (fetal calf serum, Life Technologies,
Gaithersburg, USA). The reaction was stopped by addition of
0.2% Tween-20 in 50 mM HCl and samples were boiled for
15 min to denature cellular proteins. The samples were neutral-
ized by addition of 150 mM unbuffered imidazol and concentra-
tion of cAMP was determined by a competition imunoassay
performed as previously described [8].
Protein labeling
Toxoids were labeled with the amine-reactive Alexa Fluor 488
or Dyomics 647 dyes upon binding to Phenyl-Sepharose during
the last purification step in 0.1 M NaHCO3 pH 8.3 at room
temperature for 1 hour. Unreacted dye was washed-out from the
resin with 50 mM Tris-HCl buffer (pH 8.0) and labeled toxoids
were eluted from Phenyl-Sepharose in TUE buffer (Tris 50 mM,
8M Urea, 2 mM EDTA, pH 8.0). The molar ratio of protein:dye
was approximately 1:4 for all toxoid preparations. On-column
biotinylation of rEc-CyaA toxin was performed after the DEAE-
Sepharose purification step using NHS-Sulfo-LC-Biotin (Pierce,
Rockford, IL, USA) to reach a biotin:toxin molar ratio of 20:1.
Biotin coupling was at room temperature and was stopped after
40 min by washing of the resin with 15 ml of 50 mM Tris-HCl,
pH 8.0, and then extensively with PBS (phosphate-buffered
saline). Purified biotinylated toxin was then eluted with 50 mM
HEPES, 8 M urea, and 2 mM EDTA.
Cell cultures, growth conditions and handling of cells
J774A.1 cells (ATCC TIB 67) were maintained in RPMI 1640
medium containing 10% FCS and antibiotic/antimycotic solution
(0.1 mg/ml streptomycin, 1000 U/ml penicillin and 0.25 mg/ml
amphotericin (Sigma, St. Louis, MO)). For all experiments the
RPMI 1640 medium used for cell cultivation was replaced by
Dulbecco’s modified Eagle’s medium (D-MEM) containing
1.9 mM Ca
2+ without FCS, to avoid uncontrollable chelation of
calcium ions by the phosphate ions contained in RPMI 1640
medium, as calcium is required for CyaA activity. Bone marrow
derived dendritic cells (BMDCs) from MHC Class II/EGFP
knock-in mouse [41] were flushed from the femur bone marrow
cavity with PBS/2.5% FCS, plated at approx. 10
6 cells/well in
2 ml of DMEM/25 mM HEPES/10% FCS without phenol red
but containing 5 ng/ml GM-CSF (Sigma, St. Louis, MO). Cells
were cultured on 25-mm circular cover slips, with media
replacement every second day. Non-adherent cells were removed
by gentle washing on days 2 and 4. BMDCs from conventional 6-
to 8-week-old female C57BL/6 mice were obtained from femoral
and tibial bones and cells were cultured in RPMI 1640 medium
supplemented with 10% FCS, 20 ng/ml GM-CSF and antibiotic/
antimycotic solution for 7 days, as previously described by [42].
Transfection of RAW 264.7 macrophages
RAW 264.7 (ATCC TIB 71) cells (5610
4) grown on coverslips
were maintained in RPMI medium supplemented with 10% FCS
and transfected with pEGFP constructs bearing cDNA encoding
Eps-15 (DIII) or Rab-7 (kind gift of J. Forstova, Charles
University, Prague) using a FuGENE-6 transfection reagent
(Roche).
Isolation of detergent resistant membrane and western
blotting
Detergent resistant membranes (coalesced lipid rafts) were
separated by flotation in discontinuous sucrose density gradients.
J774A.1 cells (2610
7) were washed with prewarmed DMEM and
incubated with 500 ng of CyaA-derived proteins at 37uC for
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Petri dish and extracted at 4uC in 200 ml of TBS buffer (20 mM
Tris-HCl, pH 7.5, 150 mM NaCl) containing 1% Triton X-100,
1 mM EDTA, 10 mM NaF and a Complete Mini protease
inhibitor cocktail (Roche) for 60 min. The lyzate was clarified by
centrifugation at 2506 g for 5 min and the post-nuclear
supernatant was mixed with equal volume of 90% sucrose in
TBS. The suspension was placed at the bottom of a centrifuge tube
and overlaid with 2.5 ml of 30% sucrose and 1.5 ml of 5% sucrose
in TBS. Buoyant density centrifugation was performed at
150,0006 g in a Beckman SW60Ti rotor for 16 h at 4uC.
Fractions of 0.5 ml were removed from the top of the gradient. For
immunodetection, the separated proteins were transferred onto
Immobilon-P membrane, blocked with 5% non-fat milk powder in
TBST buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05%
Tween-20) and probed with the indicated mouse monoclonal
antibody. CyaA toxoids were recognized in Western blots by the
9D4 antibody binding to the C-terminal RTX repeats of CyaA.
The signal was developed using a secondary peroxidase-conjugat-
ed sheep anti-mouse IgG and chemiluminescent detection system
(SuperSignal West Femto Maximum Sensitivity Substrate chemi-
luminescence reagent kit, Pierce, Rockford, IL).
Cell treatment and imaging
J774A.1 mouse monocytes were grown on glass coverslips to
subconfluence in the absence of the pH indicator (to avoid cellular
autofluorescence). Cells were incubated with Alexa Fluor 488-
labeled toxoid variants in serum free D-MEM medium at 37uCi n
the presence of 10 mg/ml transferrin-Dyomics 547 or in the
presence of 50 mg/ml BSA-Dyomics 547 (Exbio, Czech Republic).
For in vivo imaging, J774A.1 cells grown on glass bottom microwell
dishes (MatTek, USA) were incubated in the presence of labeled
toxoids at 37uC in HBSS medium alone, or in the presence of
inhibitors. BMDCs from day 5 were incubated for 2 hours with
1 mg/ml of Dyomics-647-labeled toxoid variants at 37uCi n
DMEM without serum. For simultaneous visualization of early
and recycling endocytic compartments, DCs were co-incubated
with 25 mg/ml transferrin-Dyomics-547 for the last 30 minutes.
Cells were fixed (4% PFA in PBS) and mounted in Mowiol. Images
were captured using a Leica confocal microscope TCS SP2
(Wetzlar, Germany) or a Cell
R Imaging Station (Olympus,
Hamburg, Germany) based on Olympus IX 81 fluorescence
microscope.
Statistical analysis of colocalization
For colocalization analysis the 3D stack of desired colour
channels was acquired comprising most of the cell volume (usually
10–15 planes in the z-axis). Analysis was performed using a macro
in WCIF ImageJ software. Special care was taken of the pixel shift
between individual colour channels (calibration with fluorescent
beads). The threshold levels for each image and channel was found
using ‘‘Huang dark’’ method. Individual cells were selected (as
ROI) and colocalization analysis was performed using an ImageJ
plug-in (http://www.uhnresearch.ca /facilities/wcif/imagej/col-
our_analysis.htm). Pearson’s correlation coefficients for each
image (individual cell recorded in all z-axis planes) were calculated
for the given channels. Usually about 60 cells were analyzed and
average Pearson’s correlation coefficient (P.c.c.) of all z-axis planes
6 standard deviation was calculated. A value of 1 represents
perfect correlation, zero represents random localization.
Quantification of endosomes
For this purpose a script based on WCIF ImageJ software was
used (see Figure S2 for detailed description).
Measuring of intracellular concentration of ions
Calcium influx into cells was measured as previously described
[14]. Briefly, the J774A.1 cells were loaded with 3 mM Fura-2/AM
(Molecular Probes) at 25uC for 30 min and time course of calcium
entry into cells after addition of CyaA-derived proteins was
determined as ratio of fluorescence excited at 340/380 nm.
Fluorescence measurement of cytosolic K
+ was performed as
described before [6]. Briefly, J774A.1 cells were loaded with
9.5 mM PBFI/AM (Molecular Probes) for 30 min at 25uC in the
presence of 0,05% (w/w) Pluronic F-127 (Sigma-Aldrich) in the
dark. Fluorescence intensity of PBFI (excitation wavelength 340,
emission wavelengths 450 and 510 nm) was recorded, ratio of
these intensities are shown in the graphs. Calibration experiments
were performed in solutions containing 50 mM HEPES (pH 7.2),
with varying concentrations of potassium acetate (10, 30, 60, or
140 mM) and sodium acetate (5, 85, 115, or 135 mM). Cellular
plasma membrane was permeabilized for potassium ions and
protons by valinomycin and nigericin (3 mM; Sigma-Aldrich) for
30 min.
Antigen presentation assays
The H-2
b-restricted T cell hybridoma CRMC3, recognizing the
NGKLIAYPIAVEALS epitope of the MalE protein from E. coli
(MalE100–114, abbreviated MalE), and the I-A
b-restricted T cell
hybridoma MF2.2D9, recognizing the IINFEKLTEWTSSNVM-
EER epitope of ovalbumin (OVA258–276), respectively, were used.
BMDC (10
5 cells/well) were pulsed with proteins or peptides for
4–5 hours, followed by medium disposal and cultivation with
CRMC3 hybridoma (10
5 cells/well) for 18 hours or the MF2.2D9
hybridoma (5610
4) for 14 hours, respectively. Prior to CRMC3
hybridoma addition the BMDCs were washed with PBS. After cell
co-incubation, cultures were frozen for at least 2 hours at 280uC.
T cell stimulation was monitored by determination of IL-2
amounts released into culture supernatants using two alternative
methods. CRMC3 culture supernatants (100 ml) were added to
cultures of the IL-2-dependent CTL-L cell line (10
4 cells/well,
final volume 200 ml) for 48 hours, followed by addition of
[
3H]thymidine (50 mCi/ml; Perkin Elmer, Courtabeuf, France).
Cells were harvested 6 hours later using an automated cell
harvester (Molecular Devices, Lier, Norway) and the incorporated
thymidine was determined by scintillation counting. The concen-
tration of IL-2 released into MF2.2D9 cell culture supernatants
was determined using a sandwich ELISA with noncompeting pairs
of anti–IL-2 mAbs (JES6-1A12 and biotinylated JES6-5H4, both
from BD Pharmingen, San Diego, CA, USA.
Supporting Information
Figure S1 CyaA constructs with the deletions in the
hydrophobic domain failed to deliver their MalE protein
for MHC Class II-restricted presentation by dendritic
cells, despite a preserved capacity to bind the CD11b/
CD18 receptor. (A) Schematic depiction of the various CyaA
variants carrying MalE protein in place of the AC domain. The
sequence encoding maltose binding protein (MalE) was amplified
from a genomic DNA of E. coli K-12 by PCR and cloned into the
pET28b vector (Novagen) for the expression of MalE-C-His, or
into the pT7CT7ACT1 plasmid (J. Holubova-Hejnova, unpub-
lished) for the expression of MalE-RTX. Plasmids for the
production of deletion variants of MalE-RTX (MalE-RTX-
D374–647, MalE-RTX-D647–855 and MalE-RTX-D374–855)
were constructed using restriction endonucleases and standard
cloning techniques. In the names of the CyaA variants the symbol
D is followed by the numbers of the first and last amino acid
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indicated by the lines. MalE protein is represented as a grey bar.
All constructs were expressed in E. coli BL-21 and purified by
chromatography on DEAE Sepharose. MalE-C-His was purified
by combination of chromatography on Amylose, Ni-NTA-Agarose
and Phenyl Sepharose. (B) Deletions in the hydrophobic domain of
CyaA partially impair CD11b/CD18 binding. CHO-CD11b/
CD18 cells were preincubated with different concentrations of
deletion variants of CyaA carrying MalE protein in place of the
AC domain (1–373) for 30 minutes on ice. Then, CyaA-biotin
(30 nM) was added and the amount of surface-bound CyaA-biotin
was determined by streptavidine-PE and flow cytometry. As a
negative control, the entire MalE-C-His protein unfused to CyaA
was used. Results are expressed as % of CyaA-biotin in the
presence of the various CyaA competitors determined as (bound
CyaA-biotin in the sample)/(maximal CyaA-biotin binding in the
absence of competitor CyaA)6100%. The results shown are
representative of two independent experiments performed in
duplicates. (C) Deletions in the hydrophobic domain of CyaA
completely abolish delivery of the MalE protein into the MHC
Class II antigen presentation pathway. BMDCs from C57BL/6
mice were incubated for 5 hours with various concentrations of
dCyaA, MalE-RTX or deletion toxoid variants. After incubation,
BMDCs were washed and incubated with anti-MalE class II
restricted specific hybridoma CRMC3 for 18 hours. The amounts
of IL-2 secreted by cell hybridoma during the 18 hours culture
were monitored using the IL-2-dependent CTL-L cell line. The
results are expressed in cpm.
(TIF)
Figure S2 Quantification of internalized endosomes. For
this purpose a script based on WCIF ImageJ (v. 143 g)
software was used (http://rsb.info.nih.gov/ij, http://
www.uhnresearch.ca/facilities/wcif/imagej). All images
were converted to monochromatic 8-bit scale and processed in
format 6726512 pixels. A copy of original image was smoothed by
Gaussian blur (radius 2.5 pixels). This blurred image was
subtracted from the original image and the result served as
template for subsequent particle (endosomal) recognition. Thresh-
old intensity was found by ‘‘MaxEntropy dark’’ automatic
algorithm and all particles brighter than the threshold and larger
than 3 pixels were recognized and recorded. For visual inspection,
original image was shown in green and recognized endosomes in
red (see picture). Due to colocalization of recognized endosomes
with the higher intensity in the original image the endosomes are
yellow. Endosomes within cell were recognized by this approach
(left panel) whereas most of the endosomes remaining attached to
the bright membrane cell membrane, or localized in its close
proximity, remained unrecognized and were not counted (right
panel). This algorithm was used repeatedly for all images of the
time series. Subsequently, individual cells in the images were
analysed semi-manually, in order to obtain average numbers of
recognized endosomes per cell. These values are plotted in the
main text Figures. Each plot shows one representative experiment
(n=3) and error bars correspond to standard deviations of
endosomal numbers for this experiment, including values form
20–40 cells.
(TIF)
Figure S3 Neither dCyaA nor dCyaA-KP colocalize with
caveolin-1. J774A.1 cells were incubated with 5 mg/ml of Alexa
Fluor 488-labeled dCyaA or dCyaA-KP at 37uC. After
5 minutes, cells were washed in cold PBS and fixed by 4%
PFA. Caveolin was labeled with anti-Caveolin-1 antibody (N-20,
rabbit polyclonal, Santa Cruz) and anti-rabbit IgG-Alexa 594
(Molecular Probes). Nuclei were stained with DAPI (2 mg/ml,
Molecular Probes). Samples were observed using an Olympus
Cell
R IX 81 microscope with a 1006 oil immersion objective
(N.A. 1.3). Values of the Pearson’s correlation coefficients for
compared channels were 0.095 and 0.060 for dCyaA and dCyaA-
KP, respectively.
(TIF)
Figure S4 Comparison of specific hemolytic activities of
native and recombinant CyaA. Sheep erythrocytes (5610
8/
ml) in Tris 50 mM, NaCl 150 mM, CaCl2 2 mM, pH 7.4 were
incubated with 2 mg/ml of recombinant (rEc-CyaA) CyaA from E.
coli or with CyaA purified from and overproducing B. pertussis
18323/pHSP9 strain (Bp-CyaA) at 37uC. Hemolytic activity was
measured as the amount of released hemoglobin by photometric
determination (A541). The results represent the average of values
obtained in two independent experiments performed in
duplicates.
(TIF)
Video S1 Endocytosis of Dyomics 647-labeled dCyaA.
J774A.1 cells were grown on glass bottom microwell dishes and
incubated for 20 minutes at 37uC with 5 mg/ml of Dyomics 647-
labeled dCyaA. Toxoid endocytosis was followed for 3 to
20 minutes of incubation by in vivo cell imaging using an Olympus
Cell
R IX 81 microscope equipped with a 606/1.35 oil objective
(UPlanSApo). Video sequences were processed using ImageJ
software, RGB 5126512 pixels, MPEG-4 video, Xvid compres-
sion, 2 frames per second.
(AVI)
Video S2 Endocytosis of Alexa Fluor 488-labeled dCyaA-
KP. J774A.1 cells grown on glass bottom microwell dishes were
incubated for 20 minutes at 37uC with 5 mg/ml of Alexa Fluor
488-labeled dCyaA-KP. Toxoid endocytosis was followed for 3 to
20 minutes of incubation by in vivo cell imaging using an Olympus
Cell
R IX 81 microscope equipped with a 606/1.35 oil objective
(UPlanSApo). Video sequences were processed using ImageJ
software, RGB 5126512 pixels, MPEG-4 video, Xvid compres-
sion, 2 frames per second.
(AVI)
Video S3 Endocytosis of Dyomics 647-labeled dCyaA-
KP in the presence of ionomycin. J774A.1 cells grown on
glass bottom microwell dishes were incubated for 20 minutes at
37uC with 5 mg/ml of Dyomics 647-labeled dCyaA-KP in the
presence of 10 mM ionomycin. Toxoid endocytosis was followed
for 3 to 20 minutes of incubation by in vivo cell imaging using an
Olympus Cell
R IX 81 microscope equipped with a 606/1.35 oil
objective (UPlanSApo). Video sequences were processed using
ImageJ software, RGB 5126512 pixels, MPEG-4 video, Xvid
compression, 2 frames per second.
(AVI)
Video S4 Endocytosis of Dyomics 647-labeled dCyaA-
KP in the presence of Alexa Fluor 488-labeled dCyaA
with J774A.1 cells grown on glass bottom microwell
dishes were incubated for 20 minutes at 376C with 5 mg/
ml of 1:1 mix of Alexa Fluor 488-labeled dCyaA with
Dyomics 647-labeled dCyaA-KP. Toxoid endocytosis was
followed for 3 to 20 minutes of incubation by in vivo cell imaging
using an Olympus Cell
R IX 81 microscope equipped with a 606/
1.35 oil objective (UPlanSApo). Video sequences were processed
using ImageJ software, RGB 5126512 pixels, MPEG-4 video,
Xvid compression, 2 frames per second.
(AVI)
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DAC. J774A.1 cells grown on glass bottom microwell dishes were
incubated for 20 minutes at 37uC with 5 mg/ml of Alexa Fluor
488-labeled CyaA-DAC. Toxoid endocytosis was followed for 3 to
20 minutes of incubation by in vivo cell imaging using an Olympus
Cell
R IX 81 microscope equipped with a 606/1.35 oil objective
(UPlanSApo). Video sequences were processed using ImageJ
software, RGB 5126512 pixels, MPEG-4 video, Xvid compres-
sion, 2 frames per second.
(AVI)
Video S6 Endocytosis of Alexa Fluor 488-labeld CyaA-
DAC in the presence of 2DG and azide. J774A.1 cells grown
on glass bottom microwell dishes were incubated for 20 minutes at
37uC with 5 mg/ml of Alexa Fluor 488-labeled CyaA-DAC in the
presence of 2DG (10 mM) and sodium azide (0.01%). Toxoid
endocytosis was followed for 3 to 20 minutes of incubation by in
vivo cell imaging using an Olympus Cell
R IX 81 microscope
equipped with a 606/1.35 oil objective (UPlanSApo). Video
sequences were processed using ImageJ software, RGB 5126512
pixels, MPEG-4 video, Xvid compression, 2 frames per second.
(AVI)
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